Captrust Financial Advisors Alector, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$7.65 - $14.24 $7,650 - $14,240	-1,000 Reduced 79.05%	265 $3,000
Q1 2022 May 16, 2022	BUY	$13.02 - $20.78 $11,119 - $17,746	854 Added 207.79%	1,265 $18,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $2,709 - $3,575	-140 Reduced 25.41%	411 $8,000
Q3 2021 Nov 16, 2021	BUY	$21.65 - $39.49 $6,191 - $11,294	286 Added 107.92%	551 $13,000
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $2,557 - $3,709	165 Added 165.0%	265 $6,000

Q1 2021 May 17, 2021	BUY	$14.84 - $22.23 $1,484 - $2,223	100 New	100 $2,000

161

59.8M

67.8K

200

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $364M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.